Global Microfluidics Market 2021-2025

世界のマイクロ流体力学市場2021-2025:体外診断、製薬研究、ドラッグデリバリーサービス

◆タイトル:Global Microfluidics Market 2021-2025
◆商品コード:IRTNTR71341
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2021年12月20日
◆ページ数:約120
◆資料形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:北米、ヨーロッパ、アジア太平洋、南米、中東・アフリカ
◆産業分野:電子
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥285,000見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥342,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥456,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

テクナビオ社は、マイクロ流体力学の世界市場規模が2021年から2025年まで年平均19.81%成長し、432.7億ドルに達すると予測しています。本調査レポートは、世界のマイクロ流体力学市場を調査・分析し、エグゼクティブサマリー、市場状況、市場規模、ファイブフォース分析、用途別(体外診断、製薬研究、ドラッグデリバリーサービス)分析、顧客状況、地域別状況、企業状況、企業分析など、以下の内容でまとめております。
・エグゼクティブサマリー
・市場状況
・市場規模
・ファイブフォース分析
・マイクロ流体力学の世界市場規模:用途別(体外診断、製薬研究、ドラッグデリバリーサービス)
・顧客状況
・地域別状況
・企業状況
・企業分析

Global Microfluidic Market For Healthcare Application 2021-2025

Technavio has been monitoring the microfluidic market for healthcare application and it is poised to grow by $ 43.27 bn during 2021-2025, progressing at a CAGR of 19.81% during the forecast period. Our report on the microfluidic market for healthcare application provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the compact size of microfluidic devices and growth in lifestyle diseases. In addition, compact size of microfluidic devices is anticipated to boost the growth of the market as well.

The microfluidic market for healthcare application analysis includes the application segment and geographic landscape.
Technavio’s microfluidic market for healthcare application is segmented as below:

By Application
• In-vitro diagnostics
• Pharmaceutical research
• Drug delivery services

By Geographical Landscape
• North America
• Europe
• APAC
• South America
• MEA

This study identifies the advances in DNA sequencingas one of the prime reasons driving the microfluidic market for healthcare application growth during the next few years.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on microfluidic market for healthcare application covers the following areas:
• Microfluidic market for healthcare application sizing
• Microfluidic market for healthcare application forecast
• Microfluidic market for healthcare application industry analysis

Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading microfluidic market for healthcare application vendors that include Agilent Technologies Inc., Bio Rad Laboratories Inc., Biocartis Group NV, BioFluidix GmbH, Danaher Corp., Fluigent SA, General Electric Co., PerkinElmer Inc., QIAGEN NV, and uFluidix Inc. Also, the microfluidic market for healthcare application analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit – https://www.technavio.com/report/microfluidic-market-for-healthcare-application-industry-analysis

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

【資料の目次】

• Executive Summary
o Market Overview
• Market Landscape
o Market ecosystem
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2020
o Market outlook: Forecast for 2020 – 2025
• Five Forces Analysis
o Five forces summary
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by Application
o Market segments
o Comparison by Application
o In-vitro diagnostics – Market size and forecast 2020-2025
o Pharmaceutical research – Market size and forecast 2020-2025
o Drug delivery services – Market size and forecast 2020-2025
o Market opportunity by Application
• Customer landscape
• Geographic Landscape
o Geographic segmentation
o Geographic comparison
o North America – Market size and forecast 2020-2025
o Europe – Market size and forecast 2020-2025
o APAC – Market size and forecast 2020-2025
o South America – Market size and forecast 2020-2025
o MEA – Market size and forecast 2020-2025
o Key leading countries
o Market opportunity By Geographical Landscape
o Market drivers
o Market challenges
o Market trends
• Vendor Landscape
o Overview
o Vendor landscape
o Landscape disruption
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o Agilent Technologies Inc.
o Bio Rad Laboratories Inc.
o Biocartis Group NV
o BioFluidix GmbH
o Danaher Corp.
o Fluigent SA
o General Electric Co.
o PerkinElmer Inc.
o QIAGEN NV
o uFluidix Inc.
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations

Exhibits
Exhibits1: Key Finding 1
Exhibits2: Key Finding 2
Exhibits3: Key Finding 3
Exhibits4: Key Finding 5
Exhibits5: Key Finding 6
Exhibits6: Key Finding 7
Exhibits7: Key Finding 8
Exhibits8: Parent market
Exhibits9: Market characteristics
Exhibits10: Offerings of vendors included in the market definition
Exhibits11: Market segments
Exhibits12: Global – Market size and forecast 2020 – 2025 ($ million)
Exhibits13: Global market: Year-over-year growth 2020 – 2025 (%)
Exhibits14: Five forces analysis 2020 & 2025
Exhibits15: Bargaining power of buyers
Exhibits16: Bargaining power of suppliers
Exhibits17: Threat of new entrants
Exhibits18: Threat of substitutes
Exhibits19: Threat of rivalry
Exhibits20: Market condition – Five forces 2020
Exhibits21: Application – Market share 2020-2025 (%)
Exhibits22: Comparison by Application
Exhibits23: In-vitro diagnostics – Market size and forecast 2020-2025 ($ million)
Exhibits24: In-vitro diagnostics – Year-over-year growth 2020-2025 (%)
Exhibits25: Pharmaceutical research – Market size and forecast 2020-2025 ($ million)
Exhibits26: Pharmaceutical research – Year-over-year growth 2020-2025 (%)
Exhibits27: Drug delivery services – Market size and forecast 2020-2025 ($ million)
Exhibits28: Drug delivery services – Year-over-year growth 2020-2025 (%)
Exhibits29: Market opportunity by Application
Exhibits30: Customer landscape
Exhibits31: Market share By Geographical Landscape 2020-2025 (%)
Exhibits32: Geographic comparison
Exhibits33: North America – Market size and forecast 2020-2025 ($ million)
Exhibits34: North America – Year-over-year growth 2020-2025 (%)
Exhibits35: Europe – Market size and forecast 2020-2025 ($ million)
Exhibits36: Europe – Year-over-year growth 2020-2025 (%)
Exhibits37: APAC – Market size and forecast 2020-2025 ($ million)
Exhibits38: APAC – Year-over-year growth 2020-2025 (%)
Exhibits39: South America – Market size and forecast 2020-2025 ($ million)
Exhibits40: South America – Year-over-year growth 2020-2025 (%)
Exhibits41: MEA – Market size and forecast 2020-2025 ($ million)
Exhibits42: MEA – Year-over-year growth 2020-2025 (%)
Exhibits43: Key leading countries
Exhibits44: Market opportunity By Geographical Landscape ($ million)
Exhibits45: Impact of drivers and challenges
Exhibits46: Vendor landscape
Exhibits47: Landscape disruption
Exhibits48: Industry risks
Exhibits49: Vendors covered
Exhibits50: Market positioning of vendors
Exhibits51: Agilent Technologies Inc. – Overview
Exhibits52: Agilent Technologies Inc. – Business segments
Exhibits53: Agilent Technologies Inc. – Key offerings
Exhibits54: Agilent Technologies Inc. – Key customers
Exhibits55: Agilent Technologies Inc. – Segment focus
Exhibits56: Bio Rad Laboratories Inc. – Overview
Exhibits57: Bio Rad Laboratories Inc. – Business segments
Exhibits58: Bio Rad Laboratories Inc. – Key offerings
Exhibits59: Bio Rad Laboratories Inc. – Key customers
Exhibits60: Bio Rad Laboratories Inc. – Segment focus
Exhibits61: Biocartis Group NV – Overview
Exhibits62: Biocartis Group NV – Business segments
Exhibits63: Biocartis Group NV – Key offerings
Exhibits64: Biocartis Group NV – Key customers
Exhibits65: Biocartis Group NV – Segment focus
Exhibits66: BioFluidix GmbH – Overview
Exhibits67: BioFluidix GmbH – Product and service
Exhibits68: BioFluidix GmbH – Key offerings
Exhibits69: BioFluidix GmbH – Key customers
Exhibits70: BioFluidix GmbH – Segment focus
Exhibits71: Danaher Corp. – Overview
Exhibits72: Danaher Corp. – Business segments
Exhibits73: Danaher Corp. – Key offerings
Exhibits74: Danaher Corp. – Key customers
Exhibits75: Danaher Corp. – Segment focus
Exhibits76: Fluigent SA – Overview
Exhibits77: Fluigent SA – Product and service
Exhibits78: Fluigent SA – Key offerings
Exhibits79: Fluigent SA – Key customers
Exhibits80: Fluigent SA – Segment focus
Exhibits81: General Electric Co. – Overview
Exhibits82: General Electric Co. – Business segments
Exhibits83: General Electric Co. – Key offerings
Exhibits84: General Electric Co. – Key customers
Exhibits85: General Electric Co. – Segment focus
Exhibits86: PerkinElmer Inc. – Overview
Exhibits87: PerkinElmer Inc. – Business segments
Exhibits88: PerkinElmer Inc. – Key offerings
Exhibits89: PerkinElmer Inc. – Key customers
Exhibits90: PerkinElmer Inc. – Segment focus
Exhibits91: QIAGEN NV – Overview
Exhibits92: QIAGEN NV – Business segments
Exhibits93: QIAGEN NV – Key offerings
Exhibits94: QIAGEN NV – Key customers
Exhibits95: QIAGEN NV – Segment focus
Exhibits96: uFluidix Inc. – Overview
Exhibits97: uFluidix Inc. – Product and service
Exhibits98: uFluidix Inc. – Key offerings
Exhibits99: uFluidix Inc. – Key customers
Exhibits100: uFluidix Inc. – Segment focus
Exhibits101: Currency conversion rates for US$
Exhibits102: Research Methodology
Exhibits103: Validation techniques employed for market sizing
Exhibits104: Information sources
Exhibits105: List of abbreviations



【掲載企業】

Agilent Technologies Inc., Bio Rad Laboratories Inc., Biocartis Group NV, BioFluidix GmbH, Danaher Corp., Fluigent SA, General Electric Co., PerkinElmer Inc., QIAGEN NV, uFluidix Inc.

【免責事項】
※当資料上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当資料に記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当資料上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[世界のマイクロ流体力学市場2021-2025:体外診断、製薬研究、ドラッグデリバリーサービス]についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆